<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2019-06-18</actionDate>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2019-07-03T15:50:23Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Drug Price Transparency for Medicare Patients Act of 2019</b></p> <p>This bill provides statutory authority for the Centers for Medicare &amp; Medicaid Services rule titled &quot;Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency,&quot; published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.</p>]]></text>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2019-06-18T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <updateDate>2019-10-23T16:44:38Z</updateDate>
    <cboCostEstimates />
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr3327ih/xml/BILLS-116hr3327ih.xml</url>
          </item>
        </formats>
        <type>Introduced in House</type>
        <date>2019-06-18T04:00:00Z</date>
      </item>
    </textVersions>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <systemCode>hswm00</systemCode>
          <type>Standing</type>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2019-06-18T04:01:00Z</date>
            </item>
          </activities>
          <name>Ways and Means Committee</name>
          <chamber>House</chamber>
        </item>
        <item>
          <subcommittees />
          <systemCode>hsif00</systemCode>
          <type>Standing</type>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2019-06-18T04:00:50Z</date>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
        </item>
      </billCommittees>
    </committees>
    <latestAction>
      <actionDate>2019-06-18</actionDate>
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      <links />
    </latestAction>
    <sponsors>
      <item>
        <identifiers>
          <bioguideId>R000607</bioguideId>
          <gpoId />
          <lisID>2323</lisID>
        </identifiers>
        <fullName>Rep. Rooney, Francis [R-FL-19]</fullName>
        <middleName />
        <party>R</party>
        <district>19</district>
        <bioguideId>R000607</bioguideId>
        <state>FL</state>
        <byRequestType />
        <firstName>Francis</firstName>
        <lastName>Rooney</lastName>
      </item>
    </sponsors>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Inflation and prices</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <amendments />
    <relatedBills />
    <recordedVotes />
    <billType>HR</billType>
    <originChamber>House</originChamber>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>To amend title XI of the Social Security Act to require that direct-to-consumer television advertisements for prescription drugs and biological products include the list price of such drugs and products, and for other purposes.</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>Drug Price Transparency for Medicare Patients Act of 2019</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>Drug Price Transparency for Medicare Patients Act of 2019</title>
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>Drug Price Transparency for Medicare Patients Act of 2019</title>
      </item>
    </titles>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 165, Number 102 (Tuesday, June 18, 2019)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. ROONEY of Florida:H.R. 3327.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8[Page H4772]</pre>]]></constitutionalAuthorityStatementText>
    <cosponsors>
      <item>
        <bioguideId>L000563</bioguideId>
        <fullName>Rep. Lipinski, Daniel [D-IL-3]</fullName>
        <sponsorshipDate>2019-07-10</sponsorshipDate>
        <state>IL</state>
        <district>3</district>
        <identifiers>
          <gpoId>7923</gpoId>
          <lisID>1781</lisID>
          <bioguideId>L000563</bioguideId>
        </identifiers>
        <party>D</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Daniel</firstName>
        <lastName>Lipinski</lastName>
        <middleName>William</middleName>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <congress>116</congress>
    <actions>
      <actionTypeCounts>
        <billReferrals>2</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <item>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <actionDate>2019-06-18</actionDate>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <committee>
          <systemCode>hswm00</systemCode>
          <name>Ways and Means Committee</name>
        </committee>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <actionDate>2019-06-18</actionDate>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <links />
        <text>Introduced in House</text>
        <actionDate>2019-06-18</actionDate>
        <actionCode>Intro-H</actionCode>
        <type>IntroReferral</type>
        <committee />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <links />
        <text>Introduced in House</text>
        <actionDate>2019-06-18</actionDate>
        <actionCode>1000</actionCode>
        <type>IntroReferral</type>
        <committee />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <laws />
    <billNumber>3327</billNumber>
    <introducedDate>2019-06-18</introducedDate>
    <version>1.0.0</version>
    <committeeReports />
    <createDate>2019-06-19T11:12:10Z</createDate>
    <notes />
    <calendarNumbers />
    <title>Drug Price Transparency for Medicare Patients Act of 2019</title>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

